Elekta AB Class B
EKTA B: XSTO (SWE)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
SEK 646.00 | Ntsc | Ypnrytv |
Pandemic and Supply Chain Issues Delay Elekta's Progress
Business Strategy and Outlook
Pandemic notwithstanding, demand for radiotherapy should stay healthy over the next decade. Elekta stands to benefit, but its success depends on its ability to commercialize Unity as well as withstand competition from Varian under Siemens Healthineers' roof.